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Abstract
Controlled differentiation of human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) into cells that
resemble adult mesenchymal stem cells (MSCs) is an attractive approach to obtain a readily available source of progenitor
cells for tissue engineering. The present study reports a new method to rapidly derive MSC-like cells from hESCs and hiPSCs,
in one step, based on culturing the cells on thin, fibrillar, type I collagen coatings that mimic the structure of physiological
collagen. Human H9 ESCs and HDFa-YK26 iPSCs were singly dissociated in the presence of ROCK inhibitor Y-27632, plated
onto fibrillar collagen coated plates and cultured in alpha minimum essential medium (alpha-MEM) supplemented with 10%
fetal bovine serum, 50 uM magnesium L-ascorbic acid phosphate and 100 nM dexamethasone. While fewer cells attached
on the collagen surface initially than standard tissue culture plastic, after culturing for 10 days, resilient colonies of
homogenous spindle-shaped cells were obtained. Flow cytometric analysis showed that a high percentage of the derived
cells expressed typical MSC surface markers including CD73, CD90, CD105, CD146 and CD166 and were negative as
expected for hematopoietic markers CD34 and CD45. The MSC-like cells derived from pluripotent cells were successfully
differentiated in vitro into three different lineages: osteogenic, chondrogenic, and adipogenic. Both H9 hES and YK26 iPS
cells displayed similar morphological changes during the derivation process and yielded MSC-like cells with similar
properties. In conclusion, this study demonstrates that bioimimetic, fibrillar, type I collagen coatings applied to cell culture
plates can be used to guide a rapid, efficient derivation of MSC-like cells from both human ES and iPS cells.
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Introduction
Human embryonic stem cells (hESCs) and induced pluripotent
stem cells (hiPSCs) are attractive stem cell sources for cell therapy
[1,2]. Multi-potent adult stem cells, such as human bone marrow
derived mesenchymal stem cells (MSCs) show promise for the
treatment of large and severe skeletal defects including repair of
damaged cartilage [3], but they are limited in number and quickly
lose their differentiation potential during expansion [4]. Differen-
tiating hESCs and hiPSCs into multi-potent progenitors or overtly
differentiated cells prior to transplantation is one of the most
promising approaches for the safe and effective use of pluripotent
stem cells. Transplantation of lineage-committed cells can avert in
vivo teratoma formation that is caused by the rapid growth and
uncontrolled spontaneous differentiation of pluripotent stem cells
[5]. However, stable and efficient differentiation of hESCs and
hiPSCs into the clinically relevant progenitor or mature cell types
remains a major challenge.
Strategies to derive MSC or MSC-like cells from hESCs have
been explored by several research groups and range from co-culture
with the desired cell type [6], to supplementation of the culture
medium with a cocktail of growth factors [7]. Uncontrolled
spontaneous differentiation in embryoid bodies followed by flow
cytometry sorting to obtain the desired phenotype has also been
employed to obtain MSCs [8]. In other studies, MSCs have been
obtained from spontaneously differentiating embryoid bodies (EBs)
or aggregates in simple culture medium without complex growth
factor supplements, although removal of the EBs and prolonged
serial passaging was required [8,9]. The cells derived by all of these
methods tested positive for established MSC surface markers and
were able to differentiate into two or three mesenchymal lineages in
vitro, i.e., osteoblastic, chondrocytic, and adipocytic. While prom-
ising in many aspects, these methods have intrinsic limitations
including complicated cell sorting, extensive culture time and
related labor cost, and, most importantly, low efficiency and yields.
For routine clinical applications, it is necessary to develop
effective, reliable, cost- and labor-efficient methods to derive MSCs
or MSC-like cells from both hESCs and hiPSCs. Besides the
addition of cytokines and growth factors, the use of appropriate
biomaterial matrices or culture surfaces offers another means to
influence cell fate through physico-chemical stimulation [10,11] and
associated signaling modulation [12,13]. Collagen type I, a
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traditional biomaterial, has long been known to promote osteogenic
differentiation of mesenchymal stem cells through an integrin-
mediated signaling pathway [14–16]. It also is known for activating
an epithelial-to-mesenchymal transition (EMT) of epithelial cells
[17–19] and EMT has been used successfully by others for
generation of MSC-like cells from hESCs [7]. Thus, we postulated
that a collagen matrix could potentially play a positive role in
regulating the differentiation of hESCs and hiPSCs towards a multi-
potent mesenchymal progenitor cell.
In the present study hESCs and hiPSCs underwent differenti-
ation while cultured on type I collagen coatings that were prepared
using an improved, highly reproducible coating method charac-
terized by the formation of a thin layer of supramolecular collagen
fibrils [20,21]. The thin coating allows excellent visibility of
cellular structures and cell-matrix interactions, and provides a
physiologically correct fibrillar collagen substrate. In contrast, the
traditional, thick, non-fibrillar collagen coatings prepared using
standard methods are limited by the inconsistency of the coating
thickness, easy coating detachment, and poor visibility of the cells
within the thick coating [16,22,23]. Multi-potentiality was assessed
through tri-lineage differentiation assays (i.e. osteogenic, chondro-
genic and adipogenic differentiation).
Additionally, we hypothesized that plating dissociated cells
versus colonies of hESCs or embryoid bodies would also
significantly increase the homogeneity of differentiation to MSC-
like cells. Plating multi-cell colonies is the established method for
passaging or differentiating hESCs and hiPSCs, yet plating singly
dissociated cells can significantly increase the differentiation yield,
as shown with osteogenic differentiation cultures [24]. According-
ly, we used singly dissociated hESCs and hiPSCs to promote the
derivation of MSC-like cells. However, dissociating hESCs and
hiPSCs by the traditional enzymatic methods generally results in
cell survival rates usually lower than 1% [24]; therefore, two
recently reported measures were taken to promote the survival of
the dissociated cells in the present study. First, we pre-treated the
cell clusters with ROCK inhibitor Y-27632 [25] and secondly, we
used the milder enzyme medium AccutaseH [26]. With this
combination, singly dissociated human pluripotent cells survived
well and thus the derivation of MSC-like cells from pluripotent
cells in a mono-layer culture on a fibrillar collagen coating could
be conducted.
Results
Derivation of MSC-like cells
The collagen films used as substrates for the cell culture studies
have a fibrillar structure as seen by scanning electron microscopy
(Fig. 1). At one day after plating, the singly dissociated hESCs and
hiPSCs were uniformly attached to the collagen coating. At 10
days after plating, however, only several isolated colonies
remained in the cultures on the collagen coating and the colonies
were predominantly located at the edge of the culture wells. Most
of the interior region of the culture well was devoid of cells. The
cells within the colonies on collagen had a spindle-like morphology
(Fig. 2A). In contrast, the cells on the control surface of tissue
culture treated polystyrene attached and grew more robustly, and
formed a tight monolayer throughout the well by day 10 (Fig. 2B).
The cells on tissue culture polystyrene did not have a spindle-
shaped morphology, and instead featured tight junction-like
structures characteristic of epithelial cells (Fig. 2B inset). After
the cells cultured on the collagen coatings were trypsinized and
sub-cultured onto new collagen films, they had a uniform
fibroblastic-like morphology (Fig. 2C). H9-hESCs and YK26-
iPSCs demonstrated similar substrate dependent attachment and
morphological changes during the derivation process with more
cells attaching and growing more robustly on tissue culture plastic.
Repeated passaging of the cells on tissue culture polystyrene did
not cause any change in morphology – the cells remained tightly
packed with an epithelial morphology.
Plating the pluripotent cells as colonies, which is the common
method for passaging hESCs and iPSCs, did not induce the cells to
attain a spindle-shape morphology on either the collagen coating
or the control tissue culture plate in this medium. A representative
image of the 10 day cultures of H9-hESCs plated as colonies are
shown Fig. 2D. A mixture of cell types with various morphologies
growing in monolayers in some areas while also forming multi-
cellular macrostructures protruding up into the medium was
observed in the cultures plated as colonies. This occurred for both
H9-hESCs and the YK26-iPSCs. We interpret these varied
morphologies as a signature of uncontrolled spontaneous differ-
entiation into multiple cell types that should be avoided when
generating a homogeneous progenitor population.
Flow cytometry was performed on the pluripotent cells that
were differentiated through the process of being passaged twice on
the collagen coating. The antigens CD73, CD90, CD105, CD146
and CD166 known to be present on adult marrow derived MSCs
[9] were expressed by a high percentage of the differentiated
pluripotent stem cell populations (Fig. 3). The hematopoietic
markers CD34 and CD45 were detected at levels below 1% (Fig. 3)
as expected for MSCs. The expression of CD90 was low relative to
the other markers at passage two, 67.5% and 82.9%, for the H9
and iPS-YK26, respectively. However, after 4 passages, the
expression of CD90 increased to 94.9% and 96.9% for H9-ESCs
and YK26-iPSCs, respectively. Because the cells derived on
collagen express a surface antigen profile similar to human bone
marrow derived MSCs and have a fibroblastic morphology similar
to MSCs, we refer to them as MSC-like cells. Note that the MSC-
like cells derived from both the H9-hECs and YK26-iPSCs shared
a very similar surface antigen profile.
Osteogenic differentiation
Evidence of the multi-potentiality of the derived cells was
assessed through tri-lineage differentiation experiments including
osteogenic, chondrogenic and adipogenic. The MSC-like cells
Figure 1. Self-assembly of Type I collagen on a tissue culture
plastic substrate leads to a thin fibrillar coating. Scanning
electron microscopy of the bioimimetic fibrillar type I collagen coating
shown prior to cell seeding (scale bar: 5 mm).
doi:10.1371/journal.pone.0033225.g001
MSCs from hESC/iPSC Using Biomimetic Collagen
PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e33225
Figure 2. Various cell morphologies were observed in response to the cell culture plate coatings. Phase contrast images of cell
morphology as a function of cell culture plate coating chemistry. Note that all the images were taken from H9-hESC cultures, but are also
representative for the corresponding YK26-iPSCs cultures. (A) The typical fibroblast-like morphology of cells obtained on the collagen coating after
10 d (P0). The cells are located in separate colonies and some areas of the plate remain open. (B) The morphology of the highly confluent cells
obtained on tissue culture treated polystyrene after 10 days. The inset shows an enlarged region (26) of the image; arrowheads indicate the tight
junction-like structure formed between cells. (C) The clear fibroblast-like morphology of cells subcultured (P1) on collagen coating for 4 days. (D) The
varied morphology of cells derived for 10 days on either tissue culture treated polystyrene or collagen coatings after plating cell colonies rather than
single cells; the arrow indicates the protrusion growing up into the medium. Scale bars for phase contrast images: 0.2 mm.
doi:10.1371/journal.pone.0033225.g002
Figure 3. Flow cytometry analysis of surface markers consistent with adult MSCs. Surface antigen profile analysis by flow cytometry for the
derived MSC-like cells. (A) and (C) are from cells derived from H9 at passage 2 and 4, respectively. (B) and (D) are from cells derived from YK26-iPSCs at
passage 2 and 4, respectively. The black histogram represents the unstained control and white overlay represents each antigen. The numeric values
shown within the histograms represent the percentage of the positive cells.
doi:10.1371/journal.pone.0033225.g003
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derived on fibrillar collagen attached and grew robustly when
passaged onto tissue culture treated plates for the osteogenic
differentiation studies. There was no obvious difference in
attachment or growth between the cells derived from H9-hESCs
or YK26-iPSCs (Fig. 4A,B). After 35 days in osteogenic medium,
mineral deposition was detected in both cultures by xylenol orange
(XO) staining (Fig. 4A,B). No XO staining was found in
undifferentiated H9-hESCs and YK26-iPSC cells cultured under
identical osteogenic conditions. The positive XO staining indicates
the presence of calcium-containing mineral deposition in the
cultures which is expected during osteogenic differentiation. Gene
expression of the MSC-like cells was assessed before and after
osteogenic differentiation. In comparison to the undifferentiated
hESCs and hiPSCs, the MSC-like cells before exposure to
osteogenic medium showed significantly greater expression of
RUNX2 and COL1A1 genes, but not alkaline phosphatase (ALP)
gene (Fig. 4C). Initially, the ALP gene expression was 1.5–2 fold
less than that of hESCs and hiPSCs which is expected since ALP
expression is very high in undifferentiated pluripotent cells. After
35 days of exposure to osteogenic medium, ALP expression was
up-regulated by 4–6 fold in MSC-like cells, while RUNX2 and
COL1A1 were maintained at significantly high levels (Fig. 4C).
ALP expression is generally regarded as an early indicator of
osteogenic differentiation. Osteocalcin (OC) and bone sialoprotein
(BSP) gene expression was not detected, which are markers for late
stage matrix-producing osteoblasts indicating the cells did not
progress completely to mature osteoblasts under these culture
conditions.
Chondrogenic differentiation
The multi-lineage potential of the MSC-like cells derived from
pluripotent cells was further assayed in a chondrogenic differenti-
ation assay performed in pellet cultures. After 21 days of culturing in
chondrogenic medium, a cartilage-like glycosaminoglycan-rich
matrix which stained positively with alcian blue was detected
throughout the histological sections of the pellet (Fig. 5A,B). Since
the cells are cultured in pellets, individual cells are not clearly
visualized in the multi-cellular pellet sections. To further confirm
that both cell types formed a cartilaginous matrix, the sections were
immunochemically stained for aggrecan and collagen type II
proteins. Both molecules were prevalent throughout the sections of
both cultures (Fig. 5A,B). No immunostaining was detected in the
negative controls (Fig. 5C). At 21 days, expression of SOX9,
COL2A1 and ACAN genes was significantly up-regulated in pellet
cultures (Fig. 5D). SOX9 was present in low amounts in
undifferentiated hESCs and the MSC-like cells before the
chondrogenic differentiation protocol. COL2A1 and aggrecan
Figure 4. In vitro osteogenic differentiation. Phase contrast images of the cells in the osteogenic cultures on day 2 and 35. (A) and (B) show
MSC-like cells derived from H9-hESC and YK26-iPSCs, respectively. The 35 day cultures were stained with xylenol orange dye (XO) to reveal mineral
deposition. The red fluorescence in the last column of images displays the positive XO staining. Scale bars: 0.2 mm. (C) RT-qPCR analysis for the mRNA
expression of osteogenic-related genes including RUNX2, COL1A1 and ALP on day 35. 1: undifferentiated H9-hESC; 2 and 3: MSC-like cells that
derived from H9-hESC and YK26-iPS cells, respectively, before osteogenic differentiation; 4 and 5: 35 day osteogenic cultures of the MSC-like cells
derived from H9-hESC and YK26-iPS cells, respectively.
doi:10.1371/journal.pone.0033225.g004
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(ACAN) genes were not detected in the undifferentiated hESCs or
in the MSC-like cells before exposure to the chondrogenic
differentiation medium. The expression of SOX9 gene in the pellet
cultures increased by 14–18 fold compared to the undifferentiated
MSC-like cells derived from both H9 and YK26-iPSCs.
Adipogenic differentiation
Adipogenic differentiation was conducted on tissue culture plates.
In response to the insulin stimulation, the MSC-like cells displayed
significant lipid accumulation in the cytoplasm which was positively
stained with Oil Red O (Fig. 6A,B). The upregulation of the
expression of the FABP4 gene further confirmed adipogenic
differentiation capability (Fig. 6C). PPARc was upregulated relative
to undifferentiated hESCs, but not enhanced by the adipogenic
differentiation protocol. No obvious difference was noticed between
cultures derived from H9 hESCs and YK26 iPSCs.
Discussion
Unlike previously reported methods which typically rely on the
addition of soluble factors to affect pluripotent stem cell differen-
tiation, the present study reports an alternative approach using a
biomaterial coating on a cell culture plate made of fibrillar collagen
Type I to promote the derivation of MSC-like cells. Both hESCs
and hiPSCs were subjected to MSC derivation on a fibrillar type I
collagen coating prepared by self-assembly from collagen solutions
on non-treated tissue culture plastic which thereby reproduces
physiological Type I collagen, i.e. collagen with individual fibrils
200–300 nm in diameter and several mm in length [27]. In the
present study, homogenous spindle-shaped cells were obtained after
10 days in the absence of complex growth factors, cytokines or
complicated manipulation of the cultures when grown on
biomimetic fibrillar collagen. The present method successfully
avoided the necessity of time consuming serial passaging and
associated cell sorting or enrichment, and simply, in one step,
homogenous MSC-like cells were obtained. The spindle-shaped
cells and their subcultures showed characteristic MSC surface
markers including being positive for CD73, CD90, CD105, CD146
and CD166, and negative for hematopoietic markers CD34 and
CD45. The cells also were capable of tri-lineage differentiation,
indicating their multi-potency, as shown through in vitro studies.
Thus the derived cells are referred to as MSC-like cells.
It is noteworthy that the MSC-like cells derived on the Type I
collagen coating displayed a unique growth pattern over time, in
that at 10 days the cells were found growing in isolated, separate
colonies mainly located near the edge of the culture wells rather
than growing as a uniform monolayer of cells. In contrast, on tissue
culture treated polystyrene (i.e., the conventional culture surface),
neither hESCs nor hiPSCs differentiated into spindle-shaped cells,
although they did have more robust sustained attachment and
growth than Type I collagen over a large area of the plate. It is not
yet known why the cells on collagen preferentially colonized the
edges better than other regions of the collagen-coated well although
the collagen coating may be slightly thicker at the plate edges.
Increasing the seeding density from 15,000 to 50,000/cm2 did not
change the growth pattern in our study, i.e., by day 10 the cells
repeatedly formed separate colonies on collagen instead of a
continuous monolayer, implying other mechanisms than cell density
were contributing to the unique growth pattern.
We did not yet identify the mechanisms underlying the
enhanced derivation process on Type I collagen in the present
study. However, other relevant studies provide clues that EMT
might have played a fundamental role in the derivation process.
EMT is known for its roles in embryogenesis, organ development,
Figure 5. In vitro chondrogenic differentiation. Positive chondrogenic matrix staining observed after chondrogenic differentiation. (A) and (B)
are images of 21d cultures of MSC-like cells derived from H9-hESC and YK26-iPSCs, respectively. Alcian blue staining of the histological sections of the
chondrogenic pellet cultures was positive. Immunohistochemical staining for aggrecan and collagen Type II on the histological sections of the 21 d
chondrogenic pellet cultures was positive. Scale bars: 0.2 mm. (C) Negative control for Col II. (D) RT-qPCR analysis for mRNA expression of
chondrogenic genes including SOX9, COL2A1 and aggrecan (ACAN). 1: undifferentiated H9-hESC; 2 and 3: MSC-like cells that derived from H9-hESC
and YK26-iPS cells, respectively, before chondrogenic differentiation; 4 and 5: 21 day chondrogenic cultures of the MSC-like cells derived from H9-
hESC and YK26-iPS cells, respectively.
doi:10.1371/journal.pone.0033225.g005
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wound healing and tissue regeneration [28]. There is evidence that
hESCs can develop an epithelial phenotype after monolayer
culture or from migration out of embryoid bodies which then
undergo EMT to acquire mesenchymal phenotype [7,8]. In the
present study, the single cells plated for 10 days on tissue culture
plates did have epithelial cell-like characteristics such as close cell
packing and tight junction-like structures (Figure 2B inset). Cells
on collagen coatings did not show such an overt epithelial-like
phenotype possibly due to their rapid transition to a mesenchymal
phenotype stimulated by the fibrillar collagen coating. A rapid
transition to MSC-like cells could also have arisen from a possible
selection process whereby slightly differentiated cells with less-
embryonic, more mature cell surface receptors were preferentially
able to attach to the Type I collagen. Type I collagen is known to
be able to stimulate and promote EMT through integrin-mediated
signaling pathways [17–19] and retain osteogenic differentiation
potential of human adult MSCs during ex vivo expansion [15].
This postulated mechanism could be addressed with the
application of integrin-blocking antibodies and will be examined
in future studies.
Dissociation of hESCs and hiPSCs into single cells was a
necessary step in the present method as evidenced by the failure of
the experiments in which traditional multi-cellular colonies were
plated. Directly plating colonies of hESCs and hiPSCs, did not
give rise to the spindle-shaped like cells on either the tissue culture
polystyrene or the collagen coating. Instead, the cell colonies
tended to develop into a mixture of various cell types judging from
the heterogeneous cell morphologies. The non-dissociated colonies
preserved the tight cell-cell interactions resembling the conditions
for EB formation, which might have similarly favored spontaneous
differentiation. We postulate that a separation of the cells from
each other forced a direct interaction of the cell surface receptors
with the substrate materials, rather than to each other, thereby
enhancing the effect of the substrate in the differentiation process.
The success of the biomaterials substrata to direct the differenti-
ation process demonstrated here further strengthens the growing
body of literature indicating that biomaterials, much like the
extracellular matrix, can direct stem cell fate [10,29].
Dexamethasone was present in the derivation medium, and
might also have positively contributed to the mesenchymal
differentiation. Dexamethasone is commonly used in osteogeneic,
chondrogeneic and adipogenic cultures [7,30] and is also used for
promoting in vitro proliferation of MSCs by boosting the effects of
other growth factors [31,32]. The addition of dexamethasone
might have expedited the differentiation process through enhance-
ment of the activity of the growth factors produced by the cells
themselves or present in the fetal bovine serum.
The tri-lineage differentiation potential of the derived MSC-like
cells was demonstrated through in vitro studies. Chondrogenic
differentiation was easily achieved as evidenced by the strong gene
expression of cartilage matrix components including aggrecan and
collagen type II and transcription factor SOX9. Histological
examination displayed a prevalent distribution of acidic glycos-
aminoglycans in the pellet. Significant production of aggrecan and
collagen type I was evidenced by immunohistochemical staining.
The adipogenic culture conditions induced apparent lipid
accumulation in the cytoplasm and adipocyte gene expression
after 21 days, although PPARc expression was unexpectedly low
given the amount of lipid droplets in the cells. Osteogenic
differentiation was demonstrated by mRNA level gene expression
of RUNX2, COL1A1 and ALP. ALP was significantly up-
regulated in response to exposure to osteogenic medium and
resulted in mineral deposition. However, late stage osteoblast
markers were not present in the cultures as evidenced by the lack
of osteocalcin and bone sialoprotein gene expression (the Ct of
real-time PCR reaction was more than 35). The inability of human
marrow derived MSCs to mature into late-stage matrix producing
osteoblasts in vitro has also been observed by other researchers
Figure 6. In vitro adipogenic differentiation. Oil red O staining of the 21 day adipogenic cultures was positive in both (A) MSC-like cells derived
from H9-hESC and (B) MSC-like cells derived from YK26-iPS cells. Scale bars: 0.1 mm. (C) RT-qPCR analysis for mRNA expression of adipogenic genes
PPARc and FABP4. 1: undifferentiated H9-hESC; 2 and 3: MSC-like cells that derived from H9-hESC and YK26-iPS cells, respectively, before adipogenic
differentiation; 4 and 5: 21 day adipogenic cultures of the MSC-like cells derived from H9-hESC and YK26-iPS cells, respectively.
doi:10.1371/journal.pone.0033225.g006
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[9,33]. The similar expression of RUNX2 and COL1A1 mRNA
before and after osteogenic differentiation observed in these MSC-
like cells derived from human pluripotent stem cells is consistent
with a previous observation during osteogenic differentiation of
human bone marrow derived MSCs [34,35]. Osteogenic differen-
tiation of the MSCs can be associated with increases in DNA-
binding activity of Runx2 without changes in mRNA level
expression [34]. It should be noted that the differentiation potential
of human adult MSCs is donor dependent [36], source tissue
dependent [37] and that repeated passaging leads to a reduced
osteogenic differentiation capacity [4]. Recently it was shown that
only 2 of 10 donors had a strong chondrogenic potential [36]. Since
there is no standard adult MSC cell source with a standard gene
expression profile at a given time point, adult MSCs were not
included as controls in these in vitro studies. Based on these
promising in vitro assay results, in vivo differentiation studies should be
pursued to conclusively demonstrate the multi-potentiality and lack
of teratoma formation of these MSC-like cells.
In conclusion, a one-step MSC derivation method from
pluripotent stem cells is reported in which singly dissociated H9
hESCs and YK26 iPSCs are cultured on biomimetic fibrillar Type
I collagen coatings to obtain MSC-like cells. Both H9-hESCs and
YK26-iPS cells responded similarly when subjected to the present
MSC derivation process on fibrillar Type I collagen. The derived
MSC-like cells from both cell lines displayed high expression levels
of surface markers typical of MSCs, and the cells demonstrated in
vitro tri-lineage differentiation potential including osteogenesis,
chondrogenesis and adipogenesis. In vivo studies are needed to fully
confirm the ability of these progenitors to function adequately in a
therapeutic setting, nonetheless multipotent stem cells with
properties resembling that of MSCs were successfully obtained.
The biomimetic fibrillar type I collagen coating played a necessary
role in the mesenchymal derivation as verified by the absence of
the transition to MSC-like cells on controls of tissue culture treated
polystyrene, although the detailed mechanism is not yet known.
Most importantly, the new method presented is not only a
convenient and efficient way to induce mesenchymal-like stem
cells from hES and iPS cells, but also demonstrates the successful
strategy of using an appropriate biomaterial matrix to influence
and direct stem cell differentiation.
Materials and Methods
Preparation of biomimetic fibrillar Type I collagen
coatings
Purified bovine Type I collagen monomer stabilized in an acidic
solution (PureCol, Inamed Biomaterials, CA) was used at a
concentration of 300 mg/ml to prepare biomimetic fibrillar
collagen coatings following a protocol developed by the National
Institute of Science and Technology (NIST) [27]. Briefly, the
collagen was diluted into a phosphate buffered saline solution
(PBS) consisting of 16 PBS: 0.1 M NaOH:106 PBS: 3 mg/ml
collagen stock solution at a 70:1:1:8 ratio (vol:vol) in a 50 ml
conical tube. The collagen stock solution was added last to
minimize the formation of insoluble aggregates. One ml of the
diluted solution was added per well in 12-well non-tissue culture
plates. After incubation at 37uC in humidified air with 5% CO2
for 12–21 hours, the gel-like supernatant was aspirated from the
plates and the coated surfaces were rinsed with PBS twice. 1 ml
PBS was added to each well to cover the coatings. The coated
plates were sealed and stored at 4uC for later use. The coating
typically comprised of Type I collagen fibrils of ,250 nm in
thickness and several microns in length (Fig. 1).
Culture of hESCs and iPSCs
H9 hESCs (WiCell, Madison, WI, USA) and human induced
pluripotent stem cell line HDFa-YK26 (YK26-iPSCs; Stem Cells
Core at UConn Health Center) [38] were maintained on
MatrigelTM (BD Biosciences, Mountain View, CA) and fed with
mouse embryonic fibroblast (MEF)-conditioned medium supple-
mented with 4 ng/ml bFGF (Invitrogen). The basal medium used
for preparing the MEF-conditioned medium contained basal
Dulbecco’s modified Eagle’s medium (DMEM)/F-12, 20%
knockout serum replacement, 2 mM nonessential amino acids,
2 mM L-glutamine (all from Invitrogen, Carlsbad, CA), and
0.1 mM beta-mercaptoethanol (Sigma-Aldrich, St. Louis, MO).
MEF cells were mitotically inactivated by gamma irradiation (irr-
MEF) for producing the MEF-conditioned medium used to culture
the hESCs and hiPSCs prior to the derivation step [39]. The
maintenance medium was replenished daily for the hESCs and
hiPSCs culture. H9 cells at passage 47 and YK26-iPSCs at passage
67 were used for the derivation.
Derivation of MSC-like cells on fibrillar collagen coatings
Before dissociation, H9-hESCs and YK26-iPSCs, maintained
on MatrigelTM, were treated with 10 uM ROCK inhibitor Y-
27632 in maintenance medium for 1 hour. Colonies were then
dissociated into single cells after incubating with 1 ml AccutaseH
per well for 10 minutes in a 37uC incubator. The cells were spun
down and re-suspended in the maintenance medium supplement-
ed with 10 uM ROCK inhibitor Y-27632. The single cells were
seeded onto the collagen coating at a density of 15,000/cm2 in the
maintenance medium. After 24 hours, the maintenance medium
was supplemented with an equal volume of the derivation medium
which contained basal alpha-MEM (Invitrogen), 10% FBS
(Hyclone), 100 U/ml penicillin and 100 ug/ml streptomycin
(Invitrogen), 100 nM dexamethasone (Sigma-Aldrich) and
50 uM magnesium L-ascorbic acid phosphate (Sigma-Aldrich).
After incubation for two more days, the medium was replenished
with the derivation medium and changed every 3–4 days
thereafter. At 10 days, the cells were harvested and labeled as
passage zero (P0). The cells were expanded on new collagen
coating using an expansion medium containing alpha-MEM
(Invitrogen), 10% MSC-qualified FBS (Hyclone), 100 U/ml
penicillin and 100 ug/ml streptomycin, 2 mM L-glutamine and
0.1 mM non-essential amino acid (all from Invitrogen). The
expansion medium was replenished every 3–4 days. Cells were
passaged upon subconfluency, usually within 5–7 days, at a 1:3
split ratio. The second passage (P2) was used for the tri-lineage
differentiation evaluation and flow cytometry analysis.
In control studies, the singly dissociated hESCs and iPSCs were
plated onto tissue culture-treated polystyrene (conventional tissue
culture plates) instead of the collagen coating, but otherwise with the
same manipulation of the cells as described above. In other controls,
hESC and iPSC colonies instead of dissociated cells were plated and
cultured on both tissue culture plates and collagen coatings. In these
studies, the cells were not treated with ROCK inhibitor Y-27632
since intact colonies of pluripotent cells survive well after passaging.
Flow Cytometry
The cells derived on the collagen coatings were passaged on the
collagen coating (P2), then the surface antigen profile was probed
by flow cytometry. A panel of surface markers typical for
characterizing human MSCs was used, including: CD73, CD90,
CD105, CD146, CD166, CD34 and CD45 [8]. Surface antigen
profiles were analyzed on a BD LSR II Flow Cytometer (Becton-
Dickinson, San Jose, CA). Cells at or near confluence were
harvested from the collagen coating using 0.05% Trysin-EDTA
and washed twice in PBS containing 15% fetal bovine serum (FBS,
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Invitrogen). After filtering through a 70 um cell strainer, cells were
spun down and then re-suspended in staining medium containing
16HBSS, 10 mM HEPES at pH 7.4 and 2% FBS. Cells were
separately labeled with fluorochrome-conjugated antibodies in-
cluding phycoerythrin (PE) conjugated anti-human CD73 anti-
body (BD Pharmingen), FITC conjugated anti-human CD90
(Thy1) antibody (eBioscience), PE conjugated anti-human CD105
antibody (eBioscience), Alexa Fluor 647 conjugated anti-human
CD146 (Biolegend), PE conjugated anti-human CD166 (Biole-
gend), FITC conjugated anti-human Stro-1 (Biolegend), FITC
conjugated anti-human CD34 antibody (BD Pharmingen), Pacific
Blue (PB) conjugated anti-human CD45 antibody (eBioscience).
After a 45 minute incubation, cells were washed twice with
staining buffer. Unstained cells were used as a control. At least
10,000 events were acquired for each sample. The data were
analyzed using FlowJo software (Tree Star Inc, Ashland, OR).
Tri-lineage differentiation
The functional differentiation ability of the derived MSC-like
cells was tested in vitro. The osteogenic medium contained alpha-
MEM (Invitrogen), 10% FBS (Hyclone), 100 U/mlpenicillin and
100 ug/ml streptomycin (Invitrogen), 100 nM dexamethasone
(Sigma-Aldrich), 50 uM magnisum L-ascorbic acid-phosphate
(Sigma-Aldrich), and 4 mM beta-glycerophosphate (Sigma-Al-
drich). Cells were seeded at density of 30,000/cm2 in 12 well tissue
culture plates (Falcon, Becton-Dickinson, NJ). Three replicates
were analyzed for each assay. The medium was replenished every
3–4 days. Mineral deposition in the osteogenic cultures was
detected by staining with 20 ug/ml xylenol orange (XO)
supplemented to the culture medium 24 hours before analysis.
XO is a fluorescent dye that has been used for labeling of calcium
phosphate mineral deposition in osteogenic cultures [40]. Positive
staining was visualized using fluorescence microscopy.
Chondrogenic differentiation assays were performed using a
standard pellet culture method [41]. The chondrogenic medium
contained high glucose DMEM (Invitrogen), 1% ITS+Premix
(Becton-Dickinson), 100 mM sodium pyruvate (Invitrogen),
10 ng/ml TGF- b1 (Peprotech), 100 nM dexamethasone (Sig-
ma-Aldrich), 120 uM magnesium L-ascorbic acid-phosphate
(Sigma-Aldrich), and 100 U/ml penicillin and 100 ug/ml strep-
tomycin (Sigma-Aldrich). The pellets were formed in 5 ml
polypropylene tubes (Becton-Dickinson) by centrifugation of
200,000 cells at 6006g for 5 min. Three replicates were analyzed
for each assay. Medium was changed every 3–4 days. Histological
examination was performed on frozen sections of the chondro-
genic pellets. Pellets were fixed in 10% neutral buffered formalin.
The sections were prepared by embedding the fixed pellets in
OCT (Tissue-Tek, Ted Pella Inc, CA) and 7 um sections were
made using a Cryostat (Leica Microsystems Inc, Bannockburn,
IL). Sections were stained with alcian blue solution which was
prepared by adding 1 g alcian blue 8 GX (Sigma-Aldrich) to
100 ml 3% acetic acid solution at pH 2.5. The sections or pellets
were soaked in alcian blue for 30 minutes, followed by rinsing with
pH 1.0 acetic acid once and pH 2.5 acetic acid twice. For
immunohistochemical analysis, sections were treated for 30 min at
37uC in 0.05% Trypsin (Invitrogen). Endogenous peroxidase
activity was quenched by incubation with 3% hydrogen peroxide
(Sigma-Aldrich) for 10 minutes at room temperature. Primary
antibodies raised against aggrecan (cat# sc-16492) and COL1A1
(cat# sc-28887) (both from Santa Cruz Biotechnology Inc, CA)
were added at 1:50 dilution and incubated for 1 hour at 37uC.
The biotin conjugated secondary antibodies recognizing immu-
noglobin of either goat (Cat#305-065-045) or rabbit (Cat#111-
065-003) (both are from Jackson ImmunoResearch Laboratories
Inc, West Grove, PA) were added at 1:1000 dilution and incubated
for 1 hour at 37uC. Streptavidin-conjugated horseradish peroxi-
dase (HRP) from an ultra-sensitive ABC peroxidase staining kit
(Pierce, Rockford, IL) was added to react with the biotin
conjugated secondary antibody for 30 minutes at 37uC, then a
diaminobenzidine (DAB) chromogenic subtrate kit (Pierce, Rock-
ford, IL) was used to develop the staining.
The adipogenic differentiation medium consisted of high
glucose DMEM (Invitrogen) supplemented with 10% FBS
(Hyclone), 1 uM dexamethasone (Sigma-Aldrich), 100 uM indo-
methacin (Sigma-Aldrich), 500 uM 3-isobutyl-1-methylxanthin
(IBMX) (Sigma-Aldrich), and 10 ug/ml insulin (Sigma-Aldrich),
and 1% penicillin and streptamycin (Invitrogen). Cells were seeded
at a density of 15,000/cm2 in 12 well tissue culture plates (Falcon,
Becton-Dickinson). Medium was replenished very 3–4 days. Lipid
production in the 21 day adipogenic cultures was examined with
Oil Red O (ORO) staining. The staining solution was prepared by
dissolving 0.7 g Oil Red powder (Sigma) in 200 ml of isopropanol
(Sigma-Aldrich), followed by dilution with distilled water at a ratio
of 3:2 (3 parts Oil Red O stock: 2 parts distilled water). Cells were
fixed with 10% formalin for 5 minutes at room temperature, then
stained with Oil Red-O for approximately 10 minutes, followed by
rinsing once with 60% isopropanol and then water.
Reverse Transcription-quantitative Polymerase Chain
Reaction (RT-qPCR)
RNA was extracted using Trizol (Invitrogen) according to
the manufacturer. Genomic DNA was removed by treatment
with DNase I following the manufacturer manual (Invitrogen).
Total 10 mg of RNA was used for cDNA synthesis using the
High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Foster City, CA) performed with the iCyclerH
Thermal Cycler (Bio-Rad Laboratories, Richard, CA)
following the manufacturer’s instructions. TaqMan Gene
Expression Assays for RUNX2 (Hs00231692_m1), COL1A1
(Hs00164004_m1), ALP (Hs00758162_m1), OC (Hs01587813_
g1), BSP (Hs00913377_m1), SOX9 (Hs00165814_m1), CO-
L2A1 (Hs00264051_m1), ACAN (Hs00153936_m1), COL10A1
(Hs00166657_m1) and GAPDH (Hs99999905_m1) were pur-
chased from Applied Biosystems. Quantitative RT-PCR reac-
tions were carried out on an ABI HT7900 system (Applied
Biosystems) following the manufacturer’s protocol. Quantifica-
tion was performed with the Delta-Delta Ct method using
GAPDH as an internal control.
For adipogenic gene analysis quantitative PCR was carried out
using the SYBR Green PCR master mix platform (ABI). Primer
pairs for GAPDH (GCACCGTCAAGGCTGAGAAC; ATGGT-
GGTGAAGACGCCAGT) and PPARc (TGCCAAAAGCAT-
TCCTGGTT; TCGCTGTCATCTAATTCCAGTGC) [42] and
FABP4 (ACTGGGCCAGGAATTTGACG; CCCCATCTAAG-
GTTATGGTGCTC) retrieved from PrimerBank [43] (Primer-
Bank ID: 168480125b1) were used.
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